During pregnancy, the energy requirements of the fetus impose changes in maternal metabolism. Increasing insulin resistance in the mother maintains nutrient flow to the growing fetus, whereas prolactin and placental lactogen counterbalance this resistance and prevent maternal hyperglycemia by driving expansion of the maternal population of insulin-producing beta cells [1] [2] [3] . However, the exact mechanisms by which the lactogenic hormones drive beta cell expansion remain uncertain. Here we show that serotonin acts downstream of lactogen signaling to stimulate beta cell proliferation. Expression of serotonin synthetic enzyme tryptophan hydroxylase-1 (Tph1) and serotonin production rose sharply in beta cells during pregnancy or after treatment with lactogens in vitro. Inhibition of serotonin synthesis by dietary tryptophan restriction or Tph inhibition blocked beta cell expansion and induced glucose intolerance in pregnant mice without affecting insulin sensitivity. Expression of the Ga q -linked serotonin receptor 5-hydroxytryptamine receptor-2b (Htr2b) in maternal islets increased during pregnancy and normalized just before parturition, whereas expression of the Ga i -linked receptor Htr1d increased at the end of pregnancy and postpartum. Blocking Htr2b signaling in pregnant mice also blocked beta cell expansion and caused glucose intolerance. These studies reveal an integrated signaling pathway linking beta cell mass to anticipated insulin need during pregnancy. Modulators of this pathway, including medications and diet, may affect the risk of gestational diabetes 4 .
Although lactogenic hormones regulate beta cell mass during pregnancy, they alone cannot explain all of the maternal changes in this process 2, [5] [6] [7] [8] . Despite persistent elevations of placental lactogen and prolactin through the end of pregnancy and the end of lactation, respectively, beta cell proliferation peaks at midgestation in rodents and drops to the normal nonpregnant rate or below by parturition, prompting rapid normalization of beta cell mass postpartum 2,9,10 ( Supplementary Fig. 1 ). Therefore, to identify other genes potentially involved in regulating maternal beta cell mass, we compared the global gene expression patterns in islets from nonpregnant and pregnant (gestational days 13-15 (G13−G15)) female mice by high-throughput sequencing of cDNA (Supplementary Table 1 and Supplementary Fig. 2 ) and by hybridization to oligonucleotide microarrays (Supplementary Table 2) .
Among the genes most markedly induced during pregnancy were Tph1 and Tph2, which encode the two isoforms of tryptophan hydroxylase, the rate-limiting enzyme in the synthesis of serotonin (5-hydroxytryptamine, 5-HT). We have observed that beta cells share with serotonergic neurons a common gene expression program and the ability to synthesize, store and secrete serotonin (Y. Ohta and M.S.G., unpublished observations). Indeed, expression of several other serotonergic transcripts was substantially increased in islets from pregnant mice, including those encoding aromatic l-amino acid decarboxylase, the enzyme that catalyzes the second and final step in serotonin synthesis, and vesicular monoamine transporter VMAT1 (encoded by Slc18a1) (Supplementary Table 1) .
Real-time RT-PCR for Tph1 and Tph2 confirmed the genomic analyses (Fig. 1a) . Expression of Tph1 and Tph2 increased from the nonpregnant baseline by G6 and peaked at G12 with 527-fold and sevenfold increases, respectively, whereas levels in gut, heart and brain did not change ( Supplementary Fig. 3a-c) . Tph1 expression remained high postpartum until the end of lactation, followed by a return to prepregnancy levels (Fig. 1a) . Western blotting with specific antiserum against Tph1 detected the induction of Tph1 protein expression in pregnant mouse islets 11 (Fig. 1b) . HPLC detected small tissue amounts of 5-HT in islets of nonpregnant mice, which increased 420-fold in islets from pregnant mice but did not change in gut (Fig. 1c,d ).
Serotonin regulates pancreatic beta cell mass during pregnancy RT-PCR amplified both Tph1 and Tph2 mRNA from beta cells purified from mice expressing EGFP in beta cells (MIP-GFP mice 12 ) (Fig. 1e) . Immunohistochemical staining detected 5-HT and TPH1 co-localized with insulin in islets from pregnant mice (Fig. 1f) and pregnant and postpartum humans (Fig. 1g,h and Supplementary  Fig. 3d) . In a test of the ability of beta cells to secrete this stored 5-HT, glucose stimulation induced secretion of insulin and 5-HT from islets isolated from pregnant mice (Fig. 1i,j) . Taken together, these data indicate that beta cells markedly increase synthesis, storage and secretion of 5-HT during pregnancy. This increase may modestly boost circulating 5-HT concentrations ( Supplementary Fig. 4 ) but probably increases local islet amounts of 5-HT much more. Therefore, we tested whether 5-HT affects beta cell function and glucose metabolism during pregnancy.
Because tryptophan is an essential amino acid and the K m of Tph for tryptophan is higher than tissue tryptophan concentrations, dietary restriction of tryptophan can sharply drop 5-HT levels 13 . We found that mice fed a tryptophan-free diet from G6 to G12 and tested at G13 (Fig. 2a) developed severe glucose intolerance compared to mice fed either a normal or histidine-free diet (Fig. 2b) . Furthermore, a less restricted diet, with 20% of normal tryptophan content, or treatment with the Tph inhibitor 4-chloro-DL-phenylalanine methyl ester hydrochloride (PCPA) also induced glucose intolerance in pregnant mice (Fig. 2c) but not in nonpregnant female mice (Fig. 2d) . These results support the conclusion that 5-HT production is necessary for the maintenance of glucose homeostasis during pregnancy.
To determine how 5-HT might regulate islet function, we assayed the expression in islets of the 14 mouse 5-HT receptors by RT-PCR 14 . Several were expressed in relatively high amounts in mouse islets (Fig. 2e) , and transcripts encoding the Gα i -linked receptor Htr1d and the Gα q -linked receptor Htr2b were detected in purified beta cells (Fig. 2f) . In pregnant mice, Htr2b expression increased significantly from G6 through G15 (Fig. 2g) and normalized at the end of gestation, whereas Htr1d expression increased at the end of gestation (G17) and postpartum (Fig. 2h) . Notably, increased Htr2b expression closely correlated with the period of increased beta cell proliferation, and increased Htr1d expression correlated with the cessation of beta cell proliferation and regression of beta cell mass 2, 9 .
To assess the contribution of 5-HT signaling, we treated mice with Htr antagonists (Fig. 2a) . The nonspecific Htr antagonist methysergide and the selective Htr2b antagonist SB204741 induced glucose intolerance in pregnant mice ( Fig. 2i) but not in nonpregnant female mice (SB204741, Fig. 2d ) or when given acutely ( Supplementary Fig. 5a ), whereas the selective Htr2a antagonist ketanserin had no effect on glucose tolerance (Fig. 2i) . Treatment with PCPA or SB204741 or a tryptophan-free diet all lowered insulin levels in pregnant mice (Fig. 2j) , but insulin sensitivity was not reduced with PCPA or SB204741 treatment (Supplementary Fig. 5b ). To test the requirement for Htr2b signaling during pregnancy genetically, we assessed Htr2b-null mice and observed glucose intolerance during pregnancy (Fig. 3a,b) . Given the known role of Htr2b signaling in driving cell proliferation in other tissues [15] [16] [17] [18] [19] [20] [21] , we tested whether 5-HT signaling contributes to increased beta cell proliferation during pregnancy. Treatment with PCPA or SB204741 as well as Htr2b loss reduced the normal increase in beta cell proliferation in pregnant mice at G13, as assayed by BrdU incorporation (Figs. 2a and 3c) and prevented the pregnancyinduced expansion of beta cell mass (Fig. 3d) but did not reduce insulin secretion acutely from islets in vitro (Supplementary Fig. 5c ). In addition, both PCPA and SB204741 attenuated the growth of the MIN6 mouse beta cell tumor line but not of NIH-3T3 mouse fibroblasts ( Supplementary Fig. 6a-c) . Therefore, expansion of beta cell mass during pregnancy requires both Tph1-driven 5-HT production and signaling through Htr2b.
To determine whether the requirement for Htr2b signaling resides specifically in the islets, we transplanted islets isolated from Htr2b +/+ or Htr2b −/− mice under the kidney capsule of Htr2b +/+ mice (Fig. 3e) and assessed beta cell proliferation in the transplanted islets during pregnancy. Although this approach removes the islets from their normal anatomical context, it avoids the use of Cre recombinase, which, when expressed under the control of pancreatic promoters, often recombines targeted genes in other tissues, as well 22 . In transplanted beta cells, pregnancy induced 5-HT production regardless of the presence of Htr2b (Fig. 3f) . However, whereas both the host and the transplanted Htr2b +/+ beta cells similarly increased BrdU incorporation during pregnancy, fewer transplanted Htr2b −/− beta cells incorporated BrdU, indicating a local requirement for Htr2b signaling in islets during pregnancy (Fig. 3g,h) .
Because the pregnancy hormones prolactin and placental lactogen stimulate beta cell proliferation 2, 3, 5, 6 and prolactin induces Tph1 expression in the mammary gland 23 , we tested the ability of lactogenic hormones to induce Tph1 expression in islets isolated from pregnant mice at G3. Moderate concentrations of prolactin (200 ng ml −1 ) increased Tph1 expression 28-fold, whereas high concentrations of prolactin (1,000 ng ml −1 ) corresponding to midgestation lactogen levels increased Tph1 expression by 147-fold (Fig. 4a) without affecting expression of Tph2, Htr1d or Htr2b (Fig. 4b-d) , which therefore may be regulated by some other pregnancy-related signals. Human placental lactogen induced Tph1 expression to similar levels in G3 mouse islets, but nonpregnant islets responded less robustly (Supplementary Fig. 6d) , consistent with evidence that prolactin receptor expression and signaling increase in islets early during pregnancy 24 (Supplementary Table 1) .
Next we tested whether 5-HT can independently induce islet cells to proliferate. Treatment of mouse islets with prolactin (1,000 ng ml −1 ) or 5-HT (10 μM) induced similar increases in proliferation, as All data are presented as means ± s.e.m. Statistical significance versus untreated control (b,c,i,j) or versus nonpregnant control (g,h) was analyzed by Student's t test: *P < 0.05; **P < 0.01; ***P < 0.001. measured by BrdU incorporation (Fig. 4e) and Ki67 staining (Supplementary Fig. 6e) . Finally, treatment of islets with 5-HT (10 μM) in vitro altered cyclin gene expression in a pattern similar to that seen in islets from pregnant mice (Fig. 4f,g ).
Taken together, these studies suggest a simple model for the regulation of beta cell mass during pregnancy (Fig. 4h) . During pregnancy, lactogenic signaling induces Tph1 expression and 5-HT synthesis in islets. 5-HT, in turn, functions in a paracrine-autocrine fashion through Gα q -coupled Htr2b to stimulate beta cell proliferation. Shortly before parturition, expression of Htr2b decreases and expression of Gα i -coupled Htr1d increases, generating an inhibitory signal capable of reducing beta cell proliferation and beta cell mass (M. Berger and M.S.G., unpublished data), so that beta cell mass returns rapidly to prepregnancy levels. Although this model focuses on the regulation of beta cell mass, increasing evidence suggests that beta cell mass influences insulin production capacity and thus the risk of diabetes [25] [26] [27] . In addition, serotonin signaling may also directly affect insulin secretion independently of its effect on beta cell mass. Finally, similar shifts in receptor expression might contribute to other peripartum changes, such as the mobilization of calcium from bone 18 that occurs with lactation.
Modulators of this pathway, including drugs, diet and genetic inheritance, may affect the risk of gestational diabetes and, possibly, the long-term risk of developing type 2 diabetes. The dual roles of serotonin in regulating mood and beta cell mass provide a possible link that could explain the association of depression with both type 2 diabetes 28 and gestational diabetes 29 , as well as the diabetogenic effects of some classes of psychiatric medications 30 . A more complete understanding of the function of this pathway may suggest improved methods for both preventing and treating diabetes.
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